Biotechnology ResearchMassachusetts, United States51-200 Employees
La Jolla Pharmaceutical Company, a subsidiary of Innoviva, Inc., is dedicated to the commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases. La Jolla markets GIAPREZA® (angiotensin II) injection and XERAVA® (eravacycline) for injection. For more information, please visit www.ljpc.com.
| La Jolla Pharmaceutical Company Email Formats | Percentage |
| FLast@ljpc.com | 85% |
| First.Last@ljpc.com | 3% |
| Last.First@ljpc.com | 2% |
| LastFir@ljpc.com | 1% |
| FirLast@ljpc.com | 2% |
| First-Last@ljpc.com | 1% |
| FirstLast@ljpc.com | 1% |
| LastFirst@ljpc.com | 1% |
| FirstL@ljpc.com | 1% |
| LastF@ljpc.com | 1% |
| L.First@ljpc.com | 1% |
| First_Last@ljpc.com | 1% |
Check if your email matches the formats in our database with our efficient email format checker tool.
| Matching Format | Percentage |
| FLast@ljpc.com | 85% |
| First.Last@ljpc.com | 3% |
| Last.First@ljpc.com | 2% |
| LastFir@ljpc.com | 1% |
| FirLast@ljpc.com | 2% |
| First-Last@ljpc.com | 1% |
| FirstLast@ljpc.com | 1% |
| LastFirst@ljpc.com | 1% |
| FirstL@ljpc.com | 1% |
| LastF@ljpc.com | 1% |
| L.First@ljpc.com | 1% |
| First_Last@ljpc.com | 1% |
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com